Advertisement

Topics

XARELTO (rivaroxaban)

17:13 EST 22nd November 2017 | BioPortfolio
  • XARELTO® is the first and only oral, selective Factor Xa inhibitor with a demonstrated safety profile in multiple indications approved by the FDA.
  • XARELTO® is a prescription medicine used to reduce the risk of stroke and blood clots in people with atrial fibrillation, not caused by a heart valve problem. For patients currently well managed on warfarin, there is limited information on how XARELTO® and warfarin compare in reducing the risk of stroke.
  • XARELTO® is also a prescription medicine used to treat deep vein thrombosis and pulmonary embolism, and to help reduce the risk of these conditions occurring again.
  • XARELTO® is also a prescription medicine used to reduce the risk of forming a blood clot in the legs and lungs of people who have just had knee or hip replacement surgery.

Source: http://www.xarelto-us.com/

Quick Search
Advertisement
 

review and buy XARELTO (rivaroxaban) market research data and corporate reports here